deuterium has been researched along with Parkinson Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaminski Schierle, GS; Phillips, JJ; Seetaloo, N; Stephens, AD; Zacharopoulou, M | 1 |
| Beal, MF; Calingasan, NY; Chiluwal, J; Milne, GL; Shchepinov, MS; Tapias, V | 1 |
| Alken, RG; Feltmann, K; Konradsson-Geuken, Å; Malmlöf, T; Schilström, B; Schneider, F; Svensson, TH | 1 |
| Cruz-Aguado, R; Galasko, D; Montine, TJ; Sadilek, M; Shaw, CA; Snyder, LR | 1 |
| Cantor, CR; Chou, VP; Langston, JW; Manning-Boğ, AB; Molinari, RJ; Pollock, E; Shchepinov, MS | 1 |
| Fremouw-Ottevangers, DC; Gerding, AM; Muskiet, FA; Nagel, GT; Thomasson, CG; Wolthers, BG | 1 |
| de Vries, JA; Fremouw-Ottevangers, DC; Muskiet, FA; Nagel, GT; Wolthers, BG | 1 |
| Bailey, BA; Boulton, AA; Durden, DA; Yu, PH | 1 |
8 other study(ies) available for deuterium and Parkinson Disease
| Article | Year |
|---|---|
Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-Synuclein.
Topics: alpha-Synuclein; Deuterium; Deuterium Exchange Measurement; Humans; Hydrogen Deuterium Exchange-Mass Spectrometry; Parkinson Disease; Protein Conformation | 2022 |
Isotope-reinforced polyunsaturated fatty acids improve Parkinson's disease-like phenotype in rats overexpressing α-synuclein.
Topics: alpha-Linolenic Acid; alpha-Synuclein; Animals; Axonal Transport; Behavior, Animal; Brain; Deuterium; Dopaminergic Neurons; Exploratory Behavior; Humans; Inflammation; Linoleic Acid; Mitochondria; Oxidative Stress; Parkinson Disease; Postural Balance; Rats; Rats, Transgenic; Substantia Nigra | 2020 |
Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Brain; Deuterium; Disease Models, Animal; Dopamine; Forelimb; Levodopa; Male; Microdialysis; Monoamine Oxidase Inhibitors; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Selegiline; Tyrosine 3-Monooxygenase | 2015 |
Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amino Acids, Diamino; Animals; Biomarkers; Calibration; Case-Control Studies; Cerebrum; Cyanobacteria Toxins; Dementia; Deuterium; Female; Gas Chromatography-Mass Spectrometry; Guam; Humans; Indicator Dilution Techniques; Liver; Magnetic Resonance Spectroscopy; Male; Mice; Middle Aged; Parkinson Disease; Sensitivity and Specificity; Washington | 2009 |
Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; alpha-Linolenic Acid; Animals; Cell Death; Corpus Striatum; Deuterium; Disease Models, Animal; Fatty Acids, Unsaturated; Linoleic Acid; Mice; Mice, Inbred C57BL; Nerve Degeneration; Oleic Acid; Oxidative Stress; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra | 2011 |
Determination of catecholamines and their 3-O-methylated metabolites in urine by mass fragmentography with use of deuterated internal standards.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Age Factors; Aged; Catecholamines; Child; Child, Preschool; Deuterium; Dopamine; Epinephrine; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Methylation; Middle Aged; Neuroblastoma; Norepinephrine; Parkinson Disease; Pheochromocytoma; Reference Values | 1979 |
Determination of 3-methoxy-4-hydroxyphenylpyruvic acid, 3,4-dihydroxyphenylethylene glycol, and 3,4-dihydroxyphenylmandelic acid in urine by mass fragmentography, with use of deuterium-labeled internal standards.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Catechols; Child; Child, Preschool; Deuterium; Dopamine; Ethylene Glycols; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Levodopa; Mandelic Acids; Methoxyhydroxyphenylglycol; Middle Aged; Neuroblastoma; Parkinson Disease; Phenylpyruvic Acids; Pheochromocytoma; Reference Standards; Reference Values; Shock, Cardiogenic | 1978 |
Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; Animals; Blood Platelets; Chromatography, High Pressure Liquid; Deamination; Decarboxylation; Deuterium; Dopamine; Female; Humans; Kinetics; Levodopa; Liver; Male; Monoamine Oxidase; Oxidation-Reduction; Parkinson Disease; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Stereoisomerism | 1986 |